share_log

Short Interest in Bioasis Technologies Inc. (OTCMKTS:BIOAF) Increases By 28.7%

Short Interest in Bioasis Technologies Inc. (OTCMKTS:BIOAF) Increases By 28.7%

在生物病技術公司（OTCMKTS：生物協會）的短期興趣增加了 28.7％
Defense World ·  2023/02/14 17:01

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 32,300 shares, a growth of 28.7% from the January 15th total of 25,100 shares. Based on an average trading volume of 246,000 shares, the days-to-cover ratio is currently 0.1 days.

生物阿西科技股份有限公司 (OTCMKTS: BIOAF — 獲得評級) 是一月份短期興趣大增長的目標.截至 1 月 31 日，共有 32,300 股的短期利息，較 1 月 15 日共 25,100 股股份增長 28.7%。根據 246,000 股的平均交易量計算，目前的日數比率為 0.1 天。

Bioasis Technologies Trading Down 20.5 %

生物園技術交易下降 20.5%

Shares of OTCMKTS BIOAF opened at $0.02 on Tuesday. The stock has a market capitalization of $1.69 million, a PE ratio of -0.71 and a beta of 0.29. The stock's fifty day simple moving average is $0.05 and its two-hundred day simple moving average is $0.10. Bioasis Technologies has a 12-month low of $0.02 and a 12-month high of $0.23.

OTCMKTS 的股份週二以 0.02 美元開盤。該股的市值為 1.69 萬美元，私募股票比率為 -0.71，貝塔值為 0.29。該股的五十天簡單移動平均線為 0.05 美元，其 200 日簡單移動平均線為 0.10 美元。生物病科技有 12 個月的低點 0.02 美元和 12 個月的高點 0.23 美元。

Get
取得
Bioasis Technologies
生物病原技術
alerts:
警報：

Bioasis Technologies Company Profile

生物科技公司簡介

(Get Rating)

(取得評分)

biOasis Technologies, Inc operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier.
生物阿西科技股份有限公司是一家生物製藥公司。它專注於神經系統疾病的診斷和治療以及腦癌，神經退行性疾病和代謝紊亂等疾病的研究和開發。其產品包括創見計劃作為其專有載體，p97 和整個血腦屏障的成像劑。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
  • Should Medtronic's Recent Colibri Patent Controversy Concern You?
  • Checkpoint Software Helps Cyber Security Stocks Bottom
  • Under Armour Stock, Gap and Crap, Here's Why
  • Is Chevron Positioned To Take Energy Sector Leadership?
  • What Does the Consumer Price Index Measure?
  • 免費獲取有關生物病原技術研究報告的副本
  • 美敦力最近的 Colibri 專利爭議應該關注您嗎？
  • 檢查點軟件幫助網絡安全股票底部
  • 在裝甲庫存，差距和廢話，這就是為什麼
  • 雪佛龍定位採取能源部門的領導地位嗎？
  • 消費者價格指數衡量什麼？

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收生物園技術的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Bioasis Technologies 和相關公司的最新新聞和分析師評級的簡要每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論